# Investigation of the Pharmacokinetics of Turoctocog Alfa in Subjects With Haemophilia A

> **NCT01692925** · PHASE1 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 15 (actual)

## Conditions studied

- Congenital Bleeding Disorder
- Haemophilia A

## Interventions

- **DRUG:** turoctocog alfa
- **DRUG:** turoctocog alfa

## Key facts

- **NCT ID:** NCT01692925
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2017-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01692925

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01692925, "Investigation of the Pharmacokinetics of Turoctocog Alfa in Subjects With Haemophilia A". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01692925. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*